Table 2 Leftover dosage after 1 and 2Â months of the follow-up observation (n, %)
Leftover dosage | After 1Â month | After 2Â months | ||||
|---|---|---|---|---|---|---|
CitriCholess | Placebo | Subtotal | CitriCholess | Placebo | Subtotal | |
0 pill | 12(25.5) | 9(18.4) | 21(21.9) | 12(25.5) | 9(18.4) | 21(21.4) |
1–10 pills | 30(63.8) | 37(75.5) | 67(69.8) | 11(22.9) | 11(22.0) | 22(22.4) |
11–16 pills | 5(10.6) | 3(6.1) | 8(8.3) | 25(52.1) | 30(60.0) | 55(56.1) |
Total | 48(100.0) | 50(100.0) | 98(100.0) | 48(100.0) | 50(100.0) | 98(100.0) |
χ2 / P | 1.626/ 0.443 | 0.843/ 0.656 | ||||